| Literature DB >> 35017841 |
Watcharee Sovijit1, Machimaporn Taesuji1, Khate Rattanamas1, Darsaniya Punyadarsaniya1, Thanongsak Mamom2, Hoa Thi Nguyen3, Sakchai Ruenphet1.
Abstract
BACKGROUND AND AIM: The selection and proper application of disinfectants are crucial to the prevention of many diseases, so disinfectants must be evaluated before being used for the prevention of African swine fever (ASF). Three disinfectant products belonging to the group of potassium hydrogen peroxymonosulfates, product A and product B, and a quaternary ammonium compound called product C, were examined in vitro for host cell cytotoxicity and the efficacy of ASF virus inactivation. The study parameters included various concentrations, exposure times, temperatures, and degrees of cytotoxicity.Entities:
Keywords: African swine fever; disinfectant; porcine alveolar macrophage cell; potassium hydrogen peroxymonosulfate; quaternary ammonium compound; virucidal efficacy
Year: 2021 PMID: 35017841 PMCID: PMC8743787 DOI: 10.14202/vetworld.2021.2936-2940
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
The percentage of alive primary PAM cells after incubation with a certain disinfectant of various concentrations.
| Dilutions | Percentage of PAM cell viability | |||
|---|---|---|---|---|
|
| ||||
| Cell control | Product A | Product B | Product C | |
| 1:200 | 100 | 40 | 0 | 0 |
| 1:400 | 100 | 90 | 0 | 0 |
| 1:800 | 100 | 100 | 90 | 0 |
| 1:1600 | 100 | 100 | 100 | 0 |
| 1:3200 | 100 | 100 | 100 | 0 |
| 1:6400 | 100 | 100 | 100 | 0 |
| 1:12,800 | 100 | 100 | 100 | 70 |
| 1:25,600 | 100 | 100 | 100 | 100 |
| 1:51,200 | 100 | 100 | 100 | 100 |
Cutoff of cells viability was indicated when live cells clung to the bottom of tissue culture microplate more than 80% of the 5-day culturing period. PAM=Porcine alveolar macrophage
Virucidal efficacy of two potassium hydrogen peroxymonosulfate disinfectants and a quaternary ammonium compound disinfectant against African swine fever virus under various concentrations, exposure times, and temperatures.
| Product | Temperature (°C) | Exposure time (min) | Virus control (log10 HAD50/mL) | Mean±SD of titer reduction (log10 HAD50/mL) | ||
|---|---|---|---|---|---|---|
|
| ||||||
| 1:200 | 1:400 | 1:800 | ||||
| A | 4 | 1 | 6.82±0.15 | 2.62±0.41 | 1.97±0.16 | 0.75±0.28 |
| 5 | 6.84±0.08 | 3.01±0.18 | 2.04±0.19 | 0.88±0.21 | ||
| 30 | 6.86±0.10 | 3.83±0.16 | 2.39±0.37 | 1.16±0.03 | ||
| 20 | 1 | 6.95±0.03 | 2.42±0.47 | 1.87±0.08 | 0.64±0.15 | |
| 5 | 6.80±0.00 | 2.61±0.35 | 1.94±0.10 | 0.82±0.00 | ||
| 30 | 6.96±0.03 | 4.05±0.22 | 2.50±0.36 | 1.30±0.01 | ||
| B | 4 | 1 | 6.76±0.07 | 2.79±0.11 | 2.41±0.36 | 1.74±0.36 |
| 5 | 6.84±0.08 | 3.12±0.13 | 2.65±0.46 | 1.94±0.28 | ||
| 30 | 6.86±0.10 | 4.32±0.02 | 3.11±0.36 | 1.97±0.27 | ||
| 20 | 1 | 6.83±0.18 | 2.71±0.36 | 2.18±0.35 | 1.62±0.43 | |
| 5 | 6.76±0.07 | 2.94±0.10 | 2.29±0.51 | 1.68±0.30 | ||
| 30 | 6.88±0.17 | 4.58±0.27 | 2.90±0.67 | 2.04±0.18 | ||
| C | 4 | 1 | 6.85±0.14 | ≥4.05±0.14 | 3.17±0.40 | 2.24±0.02 |
| 5 | 6.88±0.17 | ≥4.08±0.17 | 3.63±0.50 | 2.45±0.13 | ||
| 30 | 6.86±0.10 | ≥4.06±0.10 | ≥4.06±0.10 | 2.90±0.13 | ||
| 20 | 1 | 6.70±0.09 | ≥3.90±0.09 | 3.23±0.66 | 2.64±0.20 | |
| 5 | 6.66±0.03 | ≥3.86±0.03 | 3.64±0.37 | 2.85±0.31 | ||
| 30 | 6.80±0.13 | ≥4.00±0.13 | 3.96±0.07 | 3.32±0.29 | ||
Virus inactivation was regarded as effective when reduction factor was≥3.
Indicates that recovery virus could not be detected in that condition, so the reduction factor was showed≥mean±SD and also significantly inactivating effective. HAD=Hemadsorption, SD=Standard deviation